In a USA Today op-ed, she cites her small 25-person vegan diet study where HbA1c fell from 7.6% to 6.6%, and calls on Medicare to pay for nutrition programs.
Recap by typeshit. Full story at USA Today.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Balwinder Singh and Raman Baweja link GLP-1 use to less kidney replacement therapy in bipolar patients with CKD, and flag lithium toxicity cases.
Yale Medicine says 5% to 10% of people on GLP-1 weight loss drugs see little result, and points to diet as one factor that can blunt the effect.
24:26
A doctor's explainer sorting peptides into eight broad categories. An evergreen overview for anyone still learning the basics.
A basic rundown of Mounjaro as a type 2 diabetes medication that can also aid weight loss, plus the downsides to know.
Presented at EASD 2026, the 52-week analysis showed a 1.46 point bigger weight drop. A GlobalData analyst says head-to-head trials are still needed.
Loading…